Biohaven Pharmaceutical Stock Target Price and Analyst Consensus
| BHVN Stock | USD 44.77 8.31 15.66% |
The current analyst and expert consensus on Biohaven Pharmaceutical is Strong Buy, with 7 strong buy opinions. The current projected Biohaven Pharmaceutical target price consensus is 28.20 with 11 analyst opinions. The most common way Biohaven Pharmaceutical analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Biohaven Pharmaceutical executives and customers to further validate their buy or sell advice. Biohaven Pharmaceutical buy-or-sell recommendation module provides average expert sentiment on the projected Biohaven Pharmaceutical target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Biohaven Pharmaceutical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 25.66 | Highest Forecast 31.3 | Target Price 28.2 |
Biohaven |
It's important to approach Biohaven Pharmaceutical's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Biohaven Pharmaceutical price targets
Biohaven Pharmaceutical's stock target price is an estimate of its future price, usually made by analysts. Using Biohaven Pharmaceutical's target price to determine if it is a suitable investment can be done through the following steps:- Look at Biohaven Pharmaceutical's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Biohaven Pharmaceutical's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Biohaven Pharmaceutical Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Biohaven Pharmaceutical is a key component of Biohaven Pharmaceutical valuation and have some predictive power on the future returns of a Biohaven Pharmaceutical.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biohaven Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | USD Crypto Fund Invested one share | |
Check out Macroaxis Advice on Biohaven Pharmaceutical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Biohaven Stock analysis
When running Biohaven Pharmaceutical's price analysis, check to measure Biohaven Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biohaven Pharmaceutical is operating at the current time. Most of Biohaven Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biohaven Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biohaven Pharmaceutical's price. Additionally, you may evaluate how the addition of Biohaven Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
The data published in Biohaven Pharmaceutical's official financial statements usually reflect Biohaven Pharmaceutical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Biohaven Pharmaceutical. For example, before you start analyzing numbers published by Biohaven accountants, it's critical to develop an understanding of what Biohaven Pharmaceutical's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Biohaven Pharmaceutical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biohaven Pharmaceutical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Biohaven Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biohaven Pharmaceutical Holding. Please utilize our Beneish M Score to check the likelihood of Biohaven Pharmaceutical's management manipulating its earnings.